QR kód

Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement

Background Current guidelines and expert consensus recommend lifelong single antiplatelet therapy for patients undergoing transcatheter aortic valve replacement who have no indication for anticoagulation or dual antiplatelet therapy. However, there is no direct evidence from randomized controlled tr...

Celý popis

Uloženo v:
Hlavní autoři: Ran Liu, Yang Li, Lihua Zhang, Zhinan Lu, Zhaolin Fu, Thomas Modine, Hasan Jilahawi, Stuart Pocock, Yongjian Wu, Guangyuan Song
Médium: Artigo
Jazyk:Inglês
Vydáno: Wiley 2025-04-01
Edice:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Témata:
antiplatelet therapy
aortic stenosis
transcatheter aortic valve replacement
treatment withdrawal
On-line přístup:https://www.ahajournals.org/doi/10.1161/JAHA.124.039350
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky